Literature DB >> 16229003

Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.

Alessandro Bodini1, Ciro D'Orazio, Diego Peroni, Massimo Corradi, Giuseppina Folesani, Eugenio Baraldi, Barouk M Assael, Attilio Boner, Giorgio L Piacentini.   

Abstract

Leukotriene B(4) (LTB(4)) and interleukin-8 (IL-8) are inflammatory mediators involved in the neutrophil response to pulmonary bacterial colonization in cystic fibrosis (CF). The aim of this study was to investigate whether the LTB(4) and IL-8 levels in exhaled breath condensate (EBC) could be related to the type of bacterial colonization in CF patients. The pH level in EBC was analyzed as an estimate of airway acidification. Forty children were evaluated: 10 CF patients with P. aeruginosa, 10 CF patients with S. aureus, 10 not colonized CF patients, and 10 healthy children. LTB(4) and IL-8 in EBC were analyzed by specific enzyme immunoassay kits (EIA). The pH of EBC was measured with a pH-meter after deareation by bubbling with argon. Exhaled LTB(4) was higher in CF children with P. aeruginosa compared to those with S. aureus (P < 0.01), not colonized (P < 0.001), and healthy children (P < 0.01). Exhaled IL-8 was elevated in CF patients colonized by P. aeruginosa compared with other subgroups (vs. not colonized, P < 0.05; vs. healthy children, P < 0.001). IL-8 levels were higher in CF children with S. aureus than in healthy children (P < 0.05). There was an increase in IL-8 levels in not colonized CF patients compared with healthy children (P < 0.05). EBC pH was higher in healthy children compared to CF patients not colonized (P < 0.05). Our data suggest that EBC is suitable for evaluating neutrophil inflammatory mediators (LTB(4), IL-8, and pH) involved in the response to pulmonary bacterial colonization in CF children. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16229003     DOI: 10.1002/ppul.20336

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  22 in total

Review 1.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

2.  A pilot study of the noninvasive assessment of the lung microbiota as a potential tool for the early diagnosis of ventilator-associated pneumonia.

Authors:  Addison K May; Jacob S Brady; Joann Romano-Keeler; Wonder P Drake; Patrick R Norris; Judith M Jenkins; Richard J Isaacs; Erik M Boczko
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

3.  GSTM1 modulation of IL-8 expression in human bronchial epithelial cells exposed to ozone.

Authors:  Weidong Wu; Vinod Doreswamy; David Diaz-Sanchez; James M Samet; Matt Kesic; Lisa Dailey; Wenli Zhang; Ilona Jaspers; David B Peden
Journal:  Free Radic Biol Med       Date:  2011-05-14       Impact factor: 7.376

4.  A low dimensional dynamical model of the initial pulmonary innate response to infection.

Authors:  Todd R Young; Richard Buckalew; Addison K May; Erik M Boczko
Journal:  Math Biosci       Date:  2012-01-04       Impact factor: 2.144

Review 5.  Noninvasive monitoring of glucose levels: is exhaled breath the answer?

Authors:  Kiera Roberts; Adam Jaffe; Charles Verge; Paul S Thomas
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

Review 6.  Mechanisms and function of DUOX in epithelia of the lung.

Authors:  Horst Fischer
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

7.  Hepoxilin A(3) facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers.

Authors:  David L Tamang; Waheed Pirzai; Gregory P Priebe; David C Traficante; Gerald B Pier; John R Falck; Christophe Morisseau; Bruce D Hammock; Beth A McCormick; Karsten Gronert; Bryan P Hurley
Journal:  J Immunol       Date:  2012-10-08       Impact factor: 5.422

8.  Exhaled breath condensate adenosine tracks lung function changes in cystic fibrosis.

Authors:  Charles R Esther; Bonnie M Olsen; Feng-Chang Lin; Jason Fine; Richard C Boucher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-25       Impact factor: 5.464

Review 9.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 10.  Novel end points for clinical trials in young children with cystic fibrosis.

Authors:  Shannon J Simpson; Lauren S Mott; Charles R Esther; Stephen M Stick; Graham L Hall
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.